Elevance investors reject pro-DEI shareholder proposal
Diversity, equity and inclusion, or DEI, efforts have become a debated topic in the corporate world and beyond this year.
Health Care
-
Braun’s ‘Make Indiana Healthy Again’ plan tightens food stamp requirements, examines Hoosier nutrition
Gov. Mike Braun was joined by top Trump health officials Robert F. Kennedy Jr. and Dr. Mehmet Oz as he introduced nine executive orders signed under his “Make Indiana Healthy Again” initiative Tuesday.
Read More -
Riley Children’s Foundation unveils $300M fundraising campaign, its largest in history
The Riley Children’s Foundation unveiled the campaign, called “Every Child Deserves Riley,” during its Red For Our Kids Gala on Saturday. The effort has seen early success—they’ve already quietly raised two-thirds of the goal.
Read More -
Eli Lilly to spend $27B on four new manufacturing sites
The new manufacturing sites are expected to create create 3,000 pharmaceutical jobs and nearly 10,000 construction positions during the buildout.
Read More -
UPDATE: Lilly reports robust Q4, full-year earnings
Lilly’s fourth-quarter earnings, released before the market opened Thursday, surpassed analysts’ expectations by millions.
Read More
Articles
Zimmer Biomet ‘cementless’ partial knee implant makes Indiana debut
The Zimmer Biomet Oxford Cementless Partial Knee System received FDA approval in November, although the implant has been used in more than 300,000 procedures outside the U.S.
Indiana Supreme Court bolsters individual rights in civil commitment appeals
The Indiana Supreme Court has ruled that appeals of expired commitments are not moot if any potential collateral consequences remain.
Indianapolis-based Olio secures $11M venture investment
Olio offers a software platform that allows health systems, physician groups and insurers to coordinate patient care across different settings.
UPDATE: Roche Diagnostics to invest up to $550M in Indianapolis, adding hundreds of local jobs
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
Lilly shuffles roles amid growth in U.S. investment, diabetes and obesity treatments
The company has announced more than $50 billion in new U.S. manufacturing investments since 2020.
Trump drug price idea could cost industry $1 trillion, lobbying group says
The idea, floated by the White House as a way to help pay for the president’s tax cut plan, blindsided the pharmaceutical industry and has prompted a furious lobbying campaign.
Lilly chief scientist talks drugmaker’s new $4.5B campus, recruiting and innovation
Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the Indianapolis-based drugmaker broke ground on this week.
WeightWatchers files for bankruptcy protection to eliminate debt burden
The 62-year-old company, which has moved into the prescription drug weight loss business, hopes to emerge from bankruptcy within 45 days.
Lilly breaks ground on $4.5B foundry campus in Lebanon’s LEAP District
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of discovering new medicines and getting them to patients.
Braun signs bill scrutinizing nonprofit hospital prices
House Bill 1004’s core pricing scrutiny targets hospital systems with $2 billion or more in net patient service revenue in the state.
Elanco ramps up debt repayment, sells future royalties of flea and tick medicine for human use
Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.
Forté Sports Medicine and Orthopedics adds surgeons, Mooresville location
Carmel-based Forté Sports Medicine and Orthopedics now has 26 physicians and five offices in the Indianapolis area,
UPDATE: Lilly shares tumble after missing analyst earnings expectations
The Indianapolis-based drugmaker also reaffirmed its 2025 revenue guidance but noted that the calculation was based on existing tariff and trade policies.
Preserving young patient’s hair prompts IU surgeons’ invention
The desire to preserve a girl’s flowing hair during brain surgery led to the development of a comb-like device that could help cranial surgery patients avoid having their heads shaved.
Indiana lawmakers send hospital pricing legislation to Braun
The legislation threatens to strip the state’s largest hospital systems of their nonprofit status if their prices exceed state average prices.
Falls by seniors a significant contributor to health care costs, Butler analysis finds
The analysis—conducted and presented by Butler University students—was the winning entry into the recent Total Cost of Care Data Challenge contest.
Elevance posts first-quarter gains after top rival struggles
Weaker results posted this month by top rival UnitedHealth had raised concerns for others in the sector.
Lawmakers seek compromise on complex hospital pricing legislation
Indiana lawmakers have discovered this legislative session that performing major financial surgery on multibillion-dollar nonprofit hospital systems is a motley and entangled task.
Report: Americans spent $71B on GLP-1 drugs in 2023
By 2023, semaglutide (Ozempic, Rybelsus and Wegovy) and tirzepatide (Mounjaro) products made up 70% of all U.S. GLP-1 spending.